Literature DB >> 33491876

Nanomedicines for Endometriosis: Lessons Learned from Cancer Research.

Abraham S Moses1, Ananiya A Demessie1, Olena Taratula1, Tetiana Korzun1, Ov D Slayden2, Oleh Taratula1.   

Abstract

Endometriosis is an incurable gynecological disease characterized by the abnormal growth of endometrium-like tissue, characteristic of the uterine lining, outside of the uterine cavity. Millions of people with endometriosis suffer from pelvic pain and infertility. This review aims to discuss whether nanomedicines that are promising therapeutic approaches for various diseases have the potential to create a paradigm shift in endometriosis management. For the first time, the available reports and achievements in the field of endometriosis nanomedicine are critically evaluated, and a summary of how nanoparticle-based systems can improve endometriosis treatment and diagnosis is provided. Parallels between cancer and endometriosis are also drawn to understand whether some fundamental principles of the well-established cancer nanomedicine field can be adopted for the development of novel nanoparticle-based strategies for endometriosis. This review provides the state of the art of endometriosis nanomedicine and perspective for researchers aiming to realize and exploit the full potential of nanoparticles for treatment and imaging of the disorder.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  endometriosis; imaging; nanomedicines; nanoparticles; therapies

Year:  2021        PMID: 33491876      PMCID: PMC7928207          DOI: 10.1002/smll.202004975

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  187 in total

1.  Ultrasmall superparamagnetic iron oxides enhanced MR imaging in rats with experimentally induced endometriosis.

Authors:  Hyun Jung Lee; Hui Joong Lee; Jong Min Lee; Yongmin Chang; Seung Tae Woo
Journal:  Magn Reson Imaging       Date:  2012-05-02       Impact factor: 2.546

Review 2.  Matrix metalloproteinases: multifunctional contributors to tumor progression.

Authors:  L J McCawley; L M Matrisian
Journal:  Mol Med Today       Date:  2000-04

3.  A baboon model for inducing endometriosis.

Authors:  Asgerally T Fazleabas
Journal:  Methods Mol Med       Date:  2006

Review 4.  The Origin and Pathogenesis of Endometriosis.

Authors:  Yeh Wang; Kristen Nicholes; Ie-Ming Shih
Journal:  Annu Rev Pathol       Date:  2019-09-03       Impact factor: 23.472

Review 5.  Recent advances in endometrial angiogenesis research.

Authors:  Jane E Girling; Peter A W Rogers
Journal:  Angiogenesis       Date:  2005-10-07       Impact factor: 9.596

6.  Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

Authors:  M S O'Reilly; T Boehm; Y Shing; N Fukai; G Vasios; W S Lane; E Flynn; J R Birkhead; B R Olsen; J Folkman
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

Review 7.  A modified baboon model for endometriosis.

Authors:  Asgerally T Fazleabas; Allison Brudney; Bilgin Gurates; Daniel Chai; Serdar Bulun
Journal:  Ann N Y Acad Sci       Date:  2002-03       Impact factor: 5.691

Review 8.  The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect.

Authors:  Hiroshi Maeda
Journal:  Cancer Sci       Date:  2013-04-22       Impact factor: 6.716

Review 9.  Viral and non-viral vectors in gene therapy: technology development and clinical trials.

Authors:  Kenneth Lundstrom; Teni Boulikas
Journal:  Technol Cancer Res Treat       Date:  2003-10

10.  miR-200c suppresses endometriosis by targeting MALAT1 in vitro and in vivo.

Authors:  Zongwen Liang; Yijie Chen; Yuan Zhao; Chaoyi Xu; Anqi Zhang; Qiong Zhang; Danhan Wang; Jing He; Wenfeng Hua; Ping Duan
Journal:  Stem Cell Res Ther       Date:  2017-11-07       Impact factor: 6.832

View more
  6 in total

1.  A Mouse Model of Endometriosis with Nanoparticle Labeling for In Vivo Photoacoustic Imaging.

Authors:  Ryan M Marquardt; Md Nafiujjaman; Tae Hoon Kim; Seock-Jin Chung; Kay Hadrick; Taeho Kim; Jae-Wook Jeong
Journal:  Reprod Sci       Date:  2022-05-31       Impact factor: 2.924

2.  Targeted Nanoparticles with High Heating Efficiency for the Treatment of Endometriosis with Systemically Delivered Magnetic Hyperthermia.

Authors:  Youngrong Park; Ananiya A Demessie; Addie Luo; Olena R Taratula; Abraham S Moses; Peter Do; Leonardo Campos; Younes Jahangiri; Cory R Wyatt; Hassan A Albarqi; Khashayar Farsad; Ov D Slayden; Oleh Taratula
Journal:  Small       Date:  2022-04-17       Impact factor: 15.153

3.  Endometriosis Is Undervalued: A Call to Action.

Authors:  Katherine Ellis; Deborah Munro; Jennifer Clarke
Journal:  Front Glob Womens Health       Date:  2022-05-10

4.  Endometrial epithelial cells-derived exosomes deliver microRNA-30c to block the BCL9/Wnt/CD44 signaling and inhibit cell invasion and migration in ovarian endometriosis.

Authors:  Mengmeng Zhang; Xi Wang; Xiaomeng Xia; Xiaoling Fang; Tingting Zhang; Fengying Huang
Journal:  Cell Death Discov       Date:  2022-04-02

5.  The experiences of endometriosis patients with diagnosis and treatment in New Zealand.

Authors:  Katherine Ellis; Deborah Munro; Rachael Wood
Journal:  Front Glob Womens Health       Date:  2022-08-31

6.  Homing Peptide-Based Targeting of Tenascin-C and Fibronectin in Endometriosis.

Authors:  Lorena Simón-Gracia; Kristina Kiisholts; Vilma Petrikaitė; Allan Tobi; Merli Saare; Prakash Lingasamy; Maire Peters; Andres Salumets; Tambet Teesalu
Journal:  Nanomaterials (Basel)       Date:  2021-11-30       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.